Comment identifier les plantes de la famille Boraginaceae ?

Les Boraginaceae se caractérisent par des fleurs en grappes et des feuilles alternées.

Quels tests pour évaluer l'efficacité des Boraginaceae ?

Des études cliniques et des tests in vitro sont utilisés pour évaluer leur efficacité.

Y a-t-il des critères spécifiques pour le diagnostic ?

Le diagnostic repose sur l'identification botanique et l'analyse des propriétés médicinales.

Comment distinguer les Boraginaceae des autres familles ?

L'observation des caractéristiques florales et des feuilles aide à la distinction.

Quels outils pour identifier les Boraginaceae ?

Des guides botaniques et des applications de reconnaissance de plantes sont utiles.

Quels symptômes sont associés à l'utilisation des Boraginaceae ?

Des réactions allergiques, des troubles gastro-intestinaux ou des effets secondaires peuvent survenir.

Les Boraginaceae provoquent-elles des effets indésirables ?

Oui, certaines espèces peuvent causer des effets indésirables comme des nausées.

Quels symptômes d'intoxication peuvent survenir ?

Des symptômes tels que des vomissements, des douleurs abdominales peuvent apparaître.

Comment reconnaître une réaction allergique aux Boraginaceae ?

Des démangeaisons, éruptions cutanées ou œdème peuvent indiquer une allergie.

Les Boraginaceae peuvent-elles causer des troubles respiratoires ?

Oui, des troubles respiratoires peuvent survenir en cas d'allergie ou d'intoxication.

Comment éviter les effets indésirables des Boraginaceae ?

Il est conseillé de commencer par de faibles doses et de surveiller les réactions.

Quelles précautions prendre avant d'utiliser des Boraginaceae ?

Consulter un professionnel de santé avant utilisation, surtout en cas de maladies préexistantes.

Les Boraginaceae peuvent-elles interagir avec d'autres médicaments ?

Oui, elles peuvent interagir avec certains médicaments, il est donc important de vérifier.

Comment stocker les préparations à base de Boraginaceae ?

Conserver dans un endroit frais et sec, à l'abri de la lumière pour préserver l'efficacité.

Y a-t-il des recommandations pour l'utilisation des Boraginaceae ?

Suivre les recommandations d'un professionnel de santé et respecter les dosages conseillés.

Comment les Boraginaceae sont-elles utilisées en médecine ?

Elles sont utilisées pour traiter des inflammations, des douleurs et des troubles cutanés.

Quels remèdes à base de Boraginaceae existent ?

Des infusions, des pommades et des extraits sont couramment utilisés.

Les Boraginaceae sont-elles efficaces contre l'inflammation ?

Certaines études montrent qu'elles peuvent réduire l'inflammation et la douleur.

Comment préparer un remède à base de Boraginaceae ?

Les feuilles peuvent être infusées ou utilisées en cataplasme pour des applications topiques.

Y a-t-il des contre-indications pour les traitements à base de Boraginaceae ?

Oui, certaines personnes, comme les femmes enceintes, doivent éviter leur utilisation.

Quelles complications peuvent survenir avec les Boraginaceae ?

Des complications comme des allergies sévères ou des troubles gastro-intestinaux peuvent survenir.

Les Boraginaceae peuvent-elles causer des problèmes hépatiques ?

Certaines espèces contiennent des composés toxiques pouvant affecter le foie.

Comment gérer une réaction allergique aux Boraginaceae ?

Cesser l'utilisation immédiatement et consulter un médecin si les symptômes persistent.

Y a-t-il des risques d'intoxication avec les Boraginaceae ?

Oui, une consommation excessive peut entraîner des symptômes d'intoxication.

Les Boraginaceae peuvent-elles aggraver des maladies existantes ?

Elles peuvent aggraver certaines conditions, comme les maladies hépatiques ou rénales.

Qui est à risque d'allergies aux Boraginaceae ?

Les personnes ayant des antécédents d'allergies aux plantes sont plus à risque.

Les femmes enceintes doivent-elles éviter les Boraginaceae ?

Oui, il est recommandé qu'elles évitent leur utilisation en raison de risques potentiels.

Quels facteurs augmentent le risque d'intoxication ?

Une consommation excessive ou l'utilisation de préparations non contrôlées augmentent le risque.

Les personnes âgées sont-elles plus vulnérables ?

Oui, elles peuvent être plus sensibles aux effets indésirables des Boraginaceae.

Y a-t-il des risques pour les personnes atteintes de maladies chroniques ?

Oui, les personnes atteintes de maladies chroniques doivent être prudentes avec leur utilisation.

Boraginaceae - Informations médicales vérifiées

Physical activity and exercise for hot flashes: trigger or treatment?

01 02 2023

DOI: 10.1097/GME.0000000000002107 PMID: 36696647

Hot flashes (HFs) are a prevalent feature of menopause. Hot flashes can be bothersome and affect quality of life. However, HFs have also been associated with the risk for cardiovascular disease. There... The PubMed database was searched between June 2020 and June 2022 for currently available evidence regarding the relation between PA and exercise and HFs. Our analysis included randomized control trial... The majority of evidence from randomized control trials indicates that aerobic and resistance exercise training lead to a decrease in subjectively experienced HFs. The limited available studies on acu...

Humans Female Hot Flashes Quality of Life Menopause +2 autres

Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.

Oct 2023

DOI: 10.1055/a-2061-7020 PMID: 37647930

Breast cancer is the most common cancer in women worldwide. Premature menopause and hot flashes are the main complications of breast cancer treatments. About 40 to 50 percent of breast cancer women wh... We aimed to evaluate and compare the efficacy of venlafaxine and citalopram on hot flashes in breast cancer women receiving tamoxifen.... We conducted a double-blind, placebo-controlled trial in forty-one, 35 to 65 years old female patients. The study lasted for four weeks, and the follow-up was for two months. Venlafaxine and citalopra... The results indicated that the total efficacy was significantly different in groups receiving citalopram, venlafaxine, and placebo. Total efficacy in the placebo group, venlafaxine, and citalopram was... Although citalopram was associated with more adverse effects, including constipation, it was more effective in reducing the frequency of hot flashes when compared to venlafaxine or placebo....

Female Humans Adult Middle Aged Aged +9 autres

Psychometric properties of the French Hot Flash Related Daily Interference Scale (HFRDIS).

06 2023

DOI: 10.1080/13697137.2022.2104634 PMID: 35940182

Hot flashes are one of the major symptoms of climacteric syndrome. Despite the high prevalence of these symptoms, few questionnaires assessing the impact of hot flashes on quality of life have been va... In this prospective study, data were obtained from two groups of women aged between 40 and 60 years from both women without breast cancer and women under hormone therapy for breast cancer between Marc... One hundred and sixty-seven women completed the HFRDIS questionnaire. The scree plots confirmed unidimensional structure. Cronbach's... The validation results show that the French version of the HFRDIS questionnaire is a valid tool to evaluate the impact of hot flashes on the daily life activities of patients....

Humans Female Adult Middle Aged Hot Flashes +6 autres

A dietary intervention for postmenopausal hot flashes: A potential role of gut microbiome. An exploratory analysis.

Dec 2023

DOI: 10.1016/j.ctim.2023.103002 PMID: 37949415

This study examined the role of gut microbiome changes in mediating the effects of a dietary intervention on the frequency and severity of postmenopausal vasomotor symptoms METHODS: Postmenopausal wom... In the subset for which microbiome testing was done, total hot flashes decreased by 95 % during the dietary intervention (p = 0.007); severe hot flashes disappeared (from 0.6 to 0.0/day; p = 0.06); an... This exploratory analysis revealed potential associations between changes in vasomotor symptoms in response to a diet change and changes in the gut microbiome. Larger randomized clinical trials are ne...

Female Humans Hot Flashes Postmenopause Gastrointestinal Microbiome +1 autres

The relationship between hot flashes and fatty acid binding protein 2 in postmenopausal women.

2022

DOI: 10.1371/journal.pone.0276391 PMID: 36260646

Hot flashes, the most bothering symptom of menopause, are linked to a metabolic inflammation. Due to estrogen deficiency in menopause, dysbiosis is observed. The intestinal barrier affects the interac... In this cross-sectional study, we divided 289 women, aged 40-65 years, into four groups based on their hot-flash severity: HF0: never experienced hot flashes; HFm: mild hot flashes; HFM: moderate hot ... The study was performed in a hospital medical center.... The hot flashes had a positive tendency toward increased levels of circulating FABP2 (P-trend = 0.001), endotoxin (P-trend = 0.031), high-sensitivity C-reactive protein (hs-CRP) (P-trend = 0.033), tum... This study shows that hot flashes are significantly associated with FABP2 levels in postmenopausal women. It suggests that severe hot flashes are linked to an increase in intestinal barrier permeabili...

Female Humans C-Reactive Protein Chemokine CCL2 Chemokine CXCL10 +10 autres

Associations of fat mass index with hot flashes and lean mass index with insomnia in middle-aged women.

04 2023

DOI: 10.1080/13697137.2023.2173566 PMID: 36779531

This cross-sectional study examined the relationship between body composition and physical and mental symptom severity in middle-aged women.... The first-visit records of 554 women aged 40-64 years were examined. The fat mass index (FMI) and lean mass index (LMI) were defined as fat mass and lean mass divided by the height squared, respective... The only menopausal symptom with significantly different severity between the high and low FMI groups was hot flashes (HF) on the Menopausal Health-Related Quality of Life Questionnaire. The factors a... The FMI was positively associated with severe HF, whereas the LMI was negatively associated with moderate-to-severe insomnia in middle-aged women....

Middle Aged Humans Female Hot Flashes Sleep Initiation and Maintenance Disorders +5 autres

Urinary phthalate metabolite concentrations and hot flash outcomes: Longitudinal associations in the Midlife Women's Health Study.

01 01 2023

DOI: 10.1016/j.envres.2022.114576 PMID: 36252832

Midlife in women is an understudied time for environmental chemical exposures and menopausal outcomes. Recent cross-sectional research links phthalates with hot flashes, but little is known regarding ...

Female Humans Pregnancy Hot Flashes Environmental Pollutants +7 autres

Acupuncture for hot flashes in hormone receptor-positive breast cancer, a coordinated multinational study: Rationale and design of the study protocol.

10 2022

DOI: 10.1016/j.cct.2022.106885 PMID: 35998768

Acupuncture has been reported to reduce hot flashes in patients with breast cancer undergoing adjuvant hormonal therapy. Although hot flashes are common, the prevalence varies among cultures, races, a... This is a coordinated multinational study, including three parallel randomized trials with a planned analysis of individual patient data, to test the effectiveness of acupuncture on hot flash-related ... Here we describe the design of a protocol for a coordinated multinational study, with attention to the complex considerations in developing a multinational research effort testing a non-pharmacologic ... clinicaltrials.gov (Identifier: NCT00797732, registered on December 21, 2018), Chinese Clinical Trial Registry (ChiCTR2100045888), and The Clinical Research Information Service (CRIS) of Korea (Regist...

Acupuncture Therapy Breast Neoplasms Female Hot Flashes Humans +2 autres

Dietary advanced glycation end-products and postmenopausal hot flashes: A post-hoc analysis of a 12-week randomized clinical trial.

Jun 2023

DOI: 10.1016/j.maturitas.2023.03.008 PMID: 37084590

Postmenopausal hot flashes are associated with an increased risk of cardiovascular disease and diabetes. Because dietary advanced glycation end-products (AGEs) may act as endocrine disruptors, this st... Postmenopausal women (n = 84) reporting ≥2 moderate-to-severe hot flashes daily were randomly assigned to either the intervention group or the control group. The former were asked to follow a low-fat,... Dietary AGEs decreased in the intervention group by 73 %, that is by 5509 ku/day on average (95 % -7009 to -4009; p < 0.001), compared with the control group (+458; 95 % CI -835 to +1751; p = 0.47; tr... The reduction in dietary AGEs with a low-fat plant-based diet was associated with a significant reduction in the frequency of severe and moderate-to-severe postmenopausal hot flashes, independent of c... ClinicalTrials.gov, NCT04587154....

Female Humans Hot Flashes Postmenopause Maillard Reaction +3 autres

A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific Cytoplasmic pollen extract for hot flashes in breast cancer survivors.

Dec 2024

DOI: 10.1080/09513590.2024.2334796 PMID: 38760920

evaluate the efficacy and tolerability of PureCyTonin against hot flashes (HF) in breast cancer survivors (BCS).... a prospective, multicenter, randomized, double-blind placebo-controlled trial was conducted in Italy.... administration of PureCyTonin or placebo, for 3 months. Effectiveness was investigated through the compilation of a daily diary for HF and of validated questionnaires (Menopause Rating Scale (MRS), Pi... 19 women were randomized to receive PureCyTonin and 20 to placebo. At T2 compared to T0, in the PureCyTonin group, we found a reduction in the number of HF (... PureCyTonin significantly reduces HF number after 3 months of therapy in BCS and it is well-tolerated....

Humans Female Hot Flashes Double-Blind Method Breast Neoplasms +9 autres

Boraginaceae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Amsinckia

Borago

Consoude

Cordia

Echium

Eriodictyon

Heliotropium

Lithospermum

Pulmonaria

Auteurs principaux

Sources (2839 au total)